John Snisarenko
Director/Board Member at ALIMERA SCIENCES, INC.
Net worth: 21 400 $ as of 29/04/2024
Profile
John Snisarenko is an Independent Director at Alimera Sciences, Inc. and a Director at Zentek Ltd.
He was previously a Vice President-Sales & Marketing at Genentech, Inc., Vice President & General Manager-Ophthalmology at Novadaq Technologies, Inc., and VP-Sales & Marketing-Ophthalmics Unit at Ciba Vision Corp.
He also served as Group Vice President-Ophthalmology Business Unit at Takeda Pharmaceuticals U.S.A., Inc. and Vice President at Novartis Pharmaceuticals Canada, Inc. and Novartis Ophthalmics, Inc. Mr. Snisarenko's education includes an undergraduate degree and an MBA from McGill University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ZENTEK LTD.
0.02% | 29/11/2023 | 20,000 ( 0.02% ) | 21 400 $ | 29/04/2024 |
ALIMERA SCIENCES, INC.
-.--% | 01/10/2023 | 0 ( -.--% ) | - $ | 29/04/2024 |
John Snisarenko active positions
| Companies | Position | Start |
|---|---|---|
| ALIMERA SCIENCES, INC. | Director/Board Member | 17/07/2019 |
| ZENTEK LTD. | Director/Board Member | 04/10/2023 |
Former positions of John Snisarenko
| Companies | Position | End |
|---|---|---|
| OYSR POIN | Corporate Officer/Principal | 30/06/2022 |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | 31/05/2019 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Sales & Marketing | 30/04/2017 |
| NOVADAQ TECHNOLOGIES INC. | Corporate Officer/Principal | 30/11/2007 |
Novartis Pharmaceuticals Canada, Inc.
 Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Corporate Officer/Principal | 31/03/2006 |
Training of John Snisarenko
| McGill University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ALIMERA SCIENCES, INC. | Health Technology |
| ZENTEK LTD. | Non-Energy Minerals |
| Private companies | 8 |
|---|---|
Novadaq Technologies, Inc.
 Novadaq Technologies, Inc. Medical SpecialtiesHealth Technology Novadaq Technologies, Inc. was engaged in the development, manufacture, and market of real-time fluorescence imaging products. The company was founded by Rick Mangat on April 14, 2000 and was headquartered in Mississauga, Canada. | Health Technology |
Ciba Vision Corp.
 Ciba Vision Corp. Electronic ComponentsElectronic Technology CIBA VISION Corp. manufactures eyeglasses, contact lenses and lens care products. It offers research, development, manufacturing contact lenses and lens care products. The company was founded in 1980 and is headquartered in Duluth, GA. | Electronic Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Oyster Point Pharma, Inc.
 Oyster Point Pharma, Inc. Pharmaceuticals: MajorHealth Technology Oyster Point Pharma, Inc. engages in the development and commercialization of pharmaceutical therapies to treat ocular surface diseases. Its product candidate, OC-01, is a nicotinic acetylcholine receptor agonist, which is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. The company was founded by Michael and is Ackermann in June 30, 2015 headquartered in Princeton, NJ. | Health Technology |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
Novartis Pharmaceuticals Canada, Inc.
Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Health Technology |
The Foundation Fighting Blindness, Inc.
 The Foundation Fighting Blindness, Inc. Miscellaneous Commercial ServicesCommercial Services The Foundation Fighting Blindness, Inc. provides preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration and usher syndrome. The firm also provides provide information on retinal degenerative diseases to all who request it, in order to increase knowledge and awareness of these diseases. It has locations in Columbia, Denver, Libertyville, New York, Plano, Raleigh and Santa Monica. The company was founded on September 16, 1971 and is headquartered in Columbia, MD. | Commercial Services |
Novartis Ophthalmics, Inc.
 Novartis Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Ophthalmics, Inc. was a producer of pharmaceuticals, eye care and generic drugs. The company was headquartered in Duluth, GA. | Health Technology |
- Stock Market
- Insiders
- John Snisarenko
